Concord Biotech Ltd. (CONCORDBIO) - Financials, balance sheet (annual)

1,926.59998 INR

75.9

4.10%

Last update Jun 6, 3:29 PM IST

Market closed

Day range

1,926.59998

1,846.80005

1,965.5

Previous close

1,850.69995

Open

1,862.30005

Access this stock data via API

Concord Biotech Ltd.

1,926.60

75.90

4.10%

Financials

Balance sheet

Fiscal date	2025	2024	2023	2022
Total assets	11.4B	17.0B	15.1B	13.1B
Current assets	11.4B	9.0B	7.3B	6.3B
Cash	—	151.4M	35.0M	6.7M
Cash equivalents	—	—	—	0
Cash and cash equivalents	—	151.4M	35.0M	6.7M
Other short term investments	—	2.7B	1.8B	1.6B
Accounts receivable	—	3.5B	2.7B	2.3B
Other receivables	—	188.8M	383.5M	268.9M
Inventory	—	2.1B	2.1B	2.0B
Prepaid assets	—	284.6M	212.0M	152.0M
Restricted cash	—	56.8M	93.7M	10.2M
Assets held for sale	—	—	—	—
Hedging assets	—	1.2M	2.5M	5.0M
Other current assets	—	284.9M	7.1M	—
Non current assets	—	8.0B	7.9B	6.8B
Properties	—	519.9M	493.8M	432.2M
Land and improvements	—	547.1M	547.1M	547.1M
Machinery furniture equipment	—	4.5B	4.3B	3.9B
Construction in progress	—	2.1B	1.7B	741.6M
Leases	—	—	—	—
Accumulated depreciation	—	-2.4B	-1.9B	-1.4B
Goodwill	—	3.2M	2.0M	35.8M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	3.2M	2.0M	35.8M
Investments and advances	—	—	—	—
Other non current assets	—	79.8M	—	—
Total liabilities	—	1.7B	2.2B	2.1B
Current liabilities	—	1.4B	1.9B	1.6B
Accounts payable	—	944.4M	938M	831.1M
Accrued expenses	—	—	—	—
Short term debt	—	78.5M	251.5M	309.3M
Deferred revenue	—	—	—	—
Tax payable	—	54.9M	90.0M	0
Pensions	—	—	274.8M	17.5M
Other current liabilities	—	62.7M	—	—
Non current liabilities	—	319.1M	321.4M	544.0M
Long term provisions	—	19.6M	—	—
Long term debt	—	18.9M	64.0M	315.6M
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	280.6M	234.4M	209.7M
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	104.6M	104.6M	104.6M	95.1M
Retained earnings	—	14.0B	11.7B	9.8B
Other shareholders equity	—	—	—	—
Total shareholders equity	—	15.3B	12.9B	11.0B
Additional paid in capital	—	819.7M	819.7M	829.2M
Treasury stock	—	—	—	—
Minority interest	—	—	—	—